Call for Abstract
Scientific Program
14th Euro Breast Cancer and Therapeutics, will be organized around the theme “Redefining Breast Cancer Treatment Through Global Collaboration and Innovation”
Euro Breast Cancer 2026 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Breast Cancer 2026
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
This session highlights the latest innovations in breast cancer screening, including AI-assisted mammography, digital breast tomosynthesis, contrast-enhanced mammography, MRI, and liquid biopsy. Experts will discuss personalized screening strategies, risk prediction models, and technologies that improve early diagnosis, reduce false-positive rates, and enhance patient outcomes.
Explore how genomic profiling, molecular diagnostics, and biomarker-driven approaches are transforming breast cancer management. Discussions will focus on BRCA mutations, HER2-low disease, multigene assays, circulating tumor DNA, and precision treatment strategies that enable personalized care and improved therapeutic outcomes.
Discover the latest breakthroughs in immunotherapy and targeted therapies, including immune checkpoint inhibitors, antibody-drug conjugates, PARP inhibitors, CDK4/6 inhibitors, novel HER2-targeted agents, and combination therapies designed to overcome resistance and improve survival.